文献速递抗菌药物管理

基于呼吸道病毒PCR的抗菌药物降阶梯管理干预实施

Implementation of a Stewardship Initiative on Respiratory Viral PCR-based Antibiotic Deescalation.
PubMed 文献 · Pharmacotherapy · 2019-05-20

本研究回顾性比较了2016年与2017年同期成人住院患者中,针对呼吸道病毒PCR阳性且使用广谱抗菌药物者实施抗菌药物管理干预前后的效果。结果显示干预未显著缩短抗菌药物降阶梯时间,但流感患者奥司他韦启动时间显著缩短。

要点

  • 仅32%的ASP警报被认为可操作,其中47%的干预被接受。
  • 抗菌药物降阶梯中位时间干预前后无显著差异(2.7天 vs 2.3天,p=0.88)。
  • 流感患者奥司他韦启动时间干预后显著缩短(11.3小时 vs 3.6小时,p=0.02)。

核心结论

  • 基于呼吸道病毒PCR的抗菌药物管理干预未显著影响抗菌药物降阶梯时间或总体抗菌药物使用。
  • 约三分之一接受广谱抗菌药物且RV PCR阳性的患者存在抗菌药物优化机会。

研究设计与样本

  • 回顾性准实验研究,比较干预前(2016年1-3月)与干预后(2017年1-3月)成人住院患者。
  • 共审查172条ASP警报,其中55条(32%)被认为可操作。

主要发现

  • 抗菌药物降阶梯中位时间干预前2.7天 vs 干预后2.3天(p=0.88)。
  • 哌拉西林-他唑巴坦停药时间从4天降至1.9天(p=0.057)。
  • 头孢曲松停药时间从2.7天降至1.8天(p=0.75)。
  • 左氧氟沙星停药时间从3.6天降至2天(p=0.4)。
  • 流感患者奥司他韦启动时间干预后显著缩短(11.3小时 vs 3.6小时,p=0.02)。

关键数值与推荐

  • 可操作警报中47%的干预被接受。

临床怎么用

  • RV PCR结果可识别抗菌药物优化机会,但单独使用不足以显著改变降阶梯行为。
  • 结合生物标志物排除细菌共感染及胸部影像学可能提高降阶梯建议的接受率。

局限性

  • 回顾性准实验设计,样本量有限,干预时间窗较短。
  • 未报告生物标志物或影像学结合干预的效果数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Respiratory viral polymerase chain reaction (RV PCR) tests assist in rapidly identifying viral pathogens and differentiating viral versus bacterial causes of pneumonia. Studies evaluating the use of RV PCR tests on antibiotic use in adults have demonstrated mixed results. We implemented an antimicrobial stewardship (ASP) intervention for patients with a positive RV PCR test result who were receiving broad-spectrum antibiotics and aimed to assess the impact on antibiotic usage. METHODS: Retrospective quasi-experimental study of adult hospitalized patients comparing time to antibiotic deescalation, duration of antibiotic therapy, and antiviral use preintervention (January-March 2016) and postintervention (January-March 2017). RESULTS: Of 172 ASP alerts reviewed, 55 (32%) were considered actionable. Of these, 47% of interventions were accepted. No significant difference was observed in median time to antibiotic deescalation (pre: 2.7 days vs post: 2.3 days, p=0.88). Time to discontinuation of antimicrobial therapy pre- and postintervention was reduced from 4 to 1.9 days (p=0.057) for piperacillin-tazobactam, from 2.7 to 1.8 days (p=0.75) for ceftriaxone, and from 3.6 to 2 days (p=0.4) for levofloxacin, respectively. Time to initiation of oseltamivir for influenza was significantly shorter in the postintervention group (pre: 11.3 hrs vs post: 3.6 hrs, p=0.02). CONCLUSION: A third of patients receiving broad-spectrum antibiotics with a positive RV PCR had an opportunity for antimicrobial optimization, although this did not translate into a significant impact on the time to antibiotic deescalation or overall antibiotic use. Combination of RV PCR results with biomarkers to rule out bacterial coinfections and chest radiographic findings may help enhance the likelihood of accepted antibiotic deescalation recommendations and represents an area of future research.

来源:Pharmacotherapy,查看原文。版权归原作者所有。

引用

  1. Srinivas P, Rivard KR, Pallotta AM, et al. Implementation of a Stewardship Initiative on Respiratory Viral PCR-based Antibiotic Deescalation. Pharmacotherapy. 2019. PMID: 31049983. doi:10.1002/phar.2268

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。